Sequential Changes of Urinary Pyridinoline and Deoxypyridinoline as Markers of Metastatic Bone Tumor in Patients with Prostate Cancer: A Preliminary Study

Japanese Journal of Clinical Oncology

Volumn 27, Issue 1, 1997, Pages 26-30

  Samma, Shoji ^d   Kagebayashi, Yoriaki ^b   Yasukawa, Motonobu ^a   Fukui, Yoshinao ^b   Ozono, Seiichiro ^b   Hirao, Yoshihiko ^b   Sato, Haruhiko ^c   Okajima, Eigoro ^b  

^a Nara Kokuho Chuo Hospital   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c SRL INC   (Japan)

^d NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bone metastasis; Prostate cancer; Serial measurement; Urinary deoxypyridinoline; Urinary pyridinoline

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID; CREATININE; DEOXYPYRIDINOLINE; PROSTATE SPECIFIC ANTIGEN; PYRIDINOLINE; TUMOR MARKER;

AGED; ARTICLE; BONE; BONE TUMOR; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY; SCINTISCANNING; URINE;

AGED; ALKALINE PHOSPHATASE; AMINO ACIDS; BONE AND BONES; BONE NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031066387     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.1.26     Document Type: Article

References (20)

1. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T. Analysis of pyridinoline, cross-linking compound of collagen fibers, in human urine. J Biochem 1983;94:1133-6.
2. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium cross-links in collagen by high-performance liquid chromatography. Anal Biochem 1984;137:380-8.
3. Segrest JP Urinary metabolites of collagen. Method Enzymol 1982;82:398-410.
4. Delmas PD. Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone 1992;13:317-321.
5. Uebelhart D, Gineyts E, Chapuy M-C, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8:87-96.
6. Paterson CR, Robins SP, Horobin JM, Preece PE, Cuschieri A. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. Brit J Cancer 1991;64:884-6.
7. Lipton A, Demers L, Daniloff Y, Curley E, Hamilton C, Harvey H et al. Increased urinary excretion of pyridinium cross-links in cancer patients. Clin Chem 1993;39:614-8.
8. Samma S, Kagebayashi Y, Yoneda T, Fukui Y, Yoshida K, Hirao Y et al Plasma pyridinium crosslinks as markers of renal osteodystrophy in patients on maintenance hemodialysis. Nippon Tosekiryoho Gakkai Zasshi 1994;27:1235-40 (in Japanese).
9. Kagebayashi Y, Samma S, Yoneda T, Arai K, Yoshida K, Maruyama Y et al. Measurement and clinical significance of serum concentrations of pyridinium cross-links in patients with renal osteodystrophy. Nippon Jinzo Gakkai Zasshi 1995;37:397-403. (in Japanese)
10. Miyamoto KK, McSherry SA, Robins SP, Besterman JM, Mohler JL. Collagen cross-link metabolites in urine as markers of bone metastasis in prostatic carcinoma J Urol 1994;151:909-13
11. Sano M, Kushida K, Takahashi T, Ohishi K, Kawana K, Okada M, Inoue T. Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone matastasis. Brit J Cancer 1994;70:701-3.
12. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988;169:197-203.
13. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988;81:195-202.
14. Arai Y, Takeuchi H, Oishi K, Yoshida O. Osteocalcin: Is it a useful marker of bone metastasis and response in advanced prostate cancer? Prostate 1992;20:169-77.
15. Stepan JJ, Mikulecky M, Bek V, Broulik P, Pacovsky V. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism. Neoplasma 1989;36:495-501.
16. Gielen F, Dequeker J, Drochmans A, Wildiers J, Merlevede M. Relevance of hydroxyproline exeretion to bone metastasis in breast cancer. Brit J Cancer 1976;34:279-85
17. Fujimoto D, Moriguchi T, Ishida T, Hayashi H. The structure of pyridinoline, a collagen crosslink. Biochem Biophys Res Commun 1978;84:52-7.
18. Coleman RE, Houston S, James I, Rodger A, Rubens RD, Leonard RCF et al. Preliminary results of the use of urinary exeretion of pyridinium crosslinks for monitoring metastatic bone disease Brit J Cancer 1992;65:766-8.
19. Lueken SA, Arnaud SB, Taylor AK, Baylink DJ. Changes in markers of bone formation and resorption in a bed rest model of weightlessness. J Bone Miner Res 1993;8:1433-8.
20. Kagebayashi Y, Samma S, Yoshida K, Ozono S, Motomiya Y, Hirao Y et al. Serum and urinary pyridinium cross-links in patients with predialysis chronic renal failure. Nippon Jinzo Gakkai Zasshi 1996;38:248-53 (in Japanese).